NCI Opens Senior Clinician Posts to Expand Cancer Research at NIH Clinical Center
The National Cancer Institute is recruiting multiple senior clinicians for its Center for Cancer Research, a signal that the intramural program is continuing to lean on physician-scientists who can bridge high-level care delivery with long-horizon experimental research. These are not routine faculty roles. The position is framed as equivalent to an academic full professor on a non-tenure clinical track, with responsibility for building and managing complex clinical programs inside the NIH Clinical Center in Bethesda, Maryland.
A strong clinical spine sits at the center of the role. Candidates are expected to bring international standing in an oncology-related specialty, substantial patient care experience, and a documented history of completing clinical research studies. The call extends to physicians in medical oncology, pathology, surgical oncology, and other procedural specialties, which makes clear that the institute is looking for leaders who can do more than supervise care. It wants clinicians capable of shaping disease-focused programs and sustaining a portfolio of investigator-initiated trials and natural history studies.
The recruitment language is unusually explicit about infrastructure and autonomy. Senior clinicians will have formal supervisory authority, access to advanced practice providers, research nurses, and patient care coordinators, and the ability to develop and hold Cooperative Research and Development Agreements with external biotechnology and pharmaceutical partners. In practical terms, the role is built for a physician who can move between bedside complexity, protocol design, and translational collaboration without losing sight of either patient safety or scientific rigor.
One sentence in the posting captures the clinical ethos of the job: the NIH Clinical Center is described as the world’s largest hospital dedicated to clinical research.
A Role Designed Around Investigator-Led Oncology Programs
The senior clinician portfolio is anchored in the Center for Cancer Research, the largest division of the NCI intramural research program. More than 220 research groups operate under that umbrella, a scale that matters because it creates dense opportunities for cross-disciplinary work in cancer biology, trial design, and precision medicine. The institute says its scientists enjoy complete intellectual freedom and are expected to pursue difficult, high-risk problems creatively, a research culture that often favors ambitious projects that might be difficult to support in conventional hospital systems.
The clinical program is housed at the NIH Clinical Center, where care is tied directly to experimental medicine. The environment is meant to support first-in-human therapeutic trials, natural history studies, and subspecialized personalized medicine evaluations carried out in unique clinics. Because treatment is provided free of charge to the American public, the setting also lowers a major barrier that can limit enrollment in rare disease and early-phase oncology studies.
That combination of high-acuity clinical work and research freedom places a premium on leadership. Senior clinicians must manage multidisciplinary teams, oversee support staff, and maintain a robust clinical trials program while also collaborating with principal investigators across disease-specific focus areas. The expected workload is not narrowly clinical and not narrowly academic; it is both, continuously.
Resources, Oversight, and the Infrastructure Behind the Job
The posting describes a well-developed support system for anyone who steps into the role. Senior clinicians will be backed by data management, protocol support, regulatory support, information systems, technology resources, and data safety monitoring. A four-year review cycle will assess the resources assigned to each clinician, including scientific and programmatic needs. In oncology research, this kind of review can shape the scope of a program as much as a budget line does, because trial load, staffing, and technical capacity all influence how quickly a team can activate studies and enroll patients.
The technology core access listed for the role is broad and clinically relevant. It includes pharmacokinetics and pharmacodynamics, protein chemistry, natural products chemistry, biophysics, mass spectrometry, advanced imaging, microscopy, proteomics, transcriptomics, genomics, bioinformatics, biostatistics, single-cell sequencing, spatial transcriptomics, flow cytometry, and mass cytometry. For cancer investigators, that menu is not decorative. It represents the experimental backbone needed to study tumor heterogeneity, drug response, immune architecture, and resistance biology in ways that connect directly back to human disease.
The NIH Clinical Center itself is presented as more than a hospital setting. Its mission is to use today’s science to develop tomorrow’s medicine, with a focus on innovative studies that can move from mechanistic insight to patient-centered testing. For senior clinicians, that means the job is positioned at the point where translational science becomes procedural reality: tissue is collected, biomarkers are interrogated, and therapeutic hypotheses are tested in real patients under close regulatory oversight.
Who Can Apply and What the Institute Is Asking For
Eligibility is tightly defined. Candidates must have completed clinical training in an oncology-related field, be at least five years beyond that training, and hold board certification in their specialty. An M.D. or equivalent degree is required, with appointment contingent on meeting NIH Clinical Center credentialing standards. The institute also expects substantial experience in patient care, research, management, and mentoring, along with national and international recognition in the relevant field.
A successful applicant will need a clear plan for using NIH Clinical Center resources. That requirement matters because the role is not a generic hire into an existing slot. It is a request for a clinician who can articulate how a program will expand, which patient populations it will serve, and how a trial portfolio will be built around the scientific strengths of the CCR infrastructure.
Candidates may be U.S. citizens, permanent residents, or eligible for an appropriate work visa. The position is subject to a background investigation. Salary is stated as commensurate with education and experience, and the federal benefits package includes retirement, health insurance, life insurance, annual and sick leave, and the Thrift Savings Plan.
Applications are being accepted on a continuous basis. Interested physicians must submit a letter of interest that includes a career synopsis and a current curriculum vitae with bibliography.
For oncology leaders who have spent years balancing patient care, protocol oversight, and mentoring, the opening is clearly built for a very specific kind of physician-investigator. The opportunity is broad, but the expectations are sharper still: sustain a high-functioning clinical research team, steward investigator-initiated trials, and use a uniquely resourced federal platform to answer questions that are difficult to study anywhere else.